ARCHIVES

J&J To Eliminate Its Ortho Biotech Unit As FDA Considers Further Limits On ESAs.

This article is from The Cancer Letter archive.

Vol. 34 No. 17 | May 2, 2008

Download PDF Visit The Full Archive

Related Articles

NCAB Committee Seeks Organ Systems Upgrade

February 7, 1986

RFA For Patient Compliance Study

September 26, 1980

AZT Trial Unblended, Controls Get Drugs; Gallo, Essex Win Lasker With Montagnier

September 26, 1986

Community Based Control Program Taking Final Shape

April 29, 1977

DCT Board Okays $3 Million In New Programs, $8 Million In Recompetitions

October 24, 1980

In Brief: Ozols Promoted At Fox Chase; Greenberger Moves To Pittsburgh; ACR Names New Officers

October 8, 1993